Cargando…

Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells

BACKGROUND: Hyperglycemia-induced advanced glycation end products (AGEs) and receptor for AGEs (RAGE) production play major roles in progression of diabetic nephropathy. Anti-RAGE effect of peroxisome proliferator-activated receptor-delta (PPARδ) agonists was shown in previous studies. PPARδ agonist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Jui-Ting, Liang, Yao-Jen, Hsu, Chia-Yu, Chen, Chao-Yi, Chen, Po-Jung, Yang, Yi-Feng, Chen, Yen-Lin, Pei, Dee, Chang, Jin-Biou, Leu, Jyh-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655807/ https://www.ncbi.nlm.nih.gov/pubmed/29065926 http://dx.doi.org/10.1186/s40360-017-0172-3

Ejemplares similares

Correction: Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells
por: Chang, Jui-Ting, et al.
Publicado: (2023)

Advanced glycation end products (AGEs) in relation to atherosclerotic lipid profiles in middle-aged and elderly diabetic patients
por: Chang, Jin-Biou, et al.
Publicado: (2011)

Glycative Stress, Glycated Hemoglobin, and Atherogenic Dyslipidemia in Patients with Hyperlipidemia
por: Yao, Chien-An, et al.
Publicado: (2023)

Involvement of Endoplasmic Reticulum Stress, Autophagy, and Apoptosis in Advanced Glycation End Products-Induced Glomerular Mesangial Cell Injury
por: Chiang, Chih-Kang, et al.
Publicado: (2016)

Cilostazol attenuates the severity of peripheral arterial occlusive disease in patients with type 2 diabetes: the role of plasma soluble receptor for advanced glycation end-products
por: Liu, Jhih-Syuan, et al.
Publicado: (2015)

Protective Effects of Kaempferitrin on Advanced Glycation End Products Induce Mesangial Cell Apoptosis and Oxidative Stress
por: Jiang, Wenxian, et al.
Publicado: (2018)

DJC Suppresses Advanced Glycation End Products-Induced JAK-STAT Signaling and ROS in Mesangial Cells
por: Sun, Min, et al.
Publicado: (2017)

Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits hyperglycemia-induced apoptosis in myocytes by suppressing receptor for advanced glycation end products expression
por: YI, BO, et al.
Publicado: (2014)

Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys
por: Lee, Eun-Jung, et al.
Publicado: (2018)

Advanced glycation end products modulate electrophysiological remodeling of right ventricular outflow tract cardiomyocytes: A novel target for diabetes‐related ventricular arrhythmogenesis
por: Chen, Yao‐Chang, et al.
Publicado: (2022)

Glucagon-like peptide-1 (GLP-1) protects vascular endothelial cells against advanced glycation end products (AGEs) – induced apoptosis
por: Zhan, Yi, et al.
Publicado: (2012)

Activation of Akt by Advanced Glycation End Products (AGEs): Involvement of IGF-1 Receptor and Caveolin-1
por: Yang, Su-Jung, et al.
Publicado: (2013)

The Influence of a Nanopatterned Scaffold that Mimics Abnormal Renal Mesangial Matrix on Mesangial Cell Behavior
por: Chang, Chia-Jung, et al.
Publicado: (2019)

Glycolaldehyde, an Advanced Glycation End Products Precursor, Induces Apoptosis via ROS-Mediated Mitochondrial Dysfunction in Renal Mesangial Cells
por: Gu, Min Ji, et al.
Publicado: (2022)

Hesperetin treatment attenuates glycation of lens proteins and advanced‑glycation end products generation
por: Doki, Yuri, et al.
Publicado: (2023)

Effects of Allium victorialis leaf extracts and its single compounds on aldose reductase, advanced glycation end products and TGF-β1 expression in mesangial cells
por: Kim, Young Sook, et al.
Publicado: (2013)

Alpha cell receptor for advanced glycation end products associate with glucagon expression in type 1 diabetes
por: Leung, Sherman S., et al.
Publicado: (2023)

Identification of Normal Blood Pressure in Different Age Group
por: Lin, Jiunn-Diann, et al.
Publicado: (2016)

Liraglutide Activates Glucagon-Like Peptide 1 Receptor to Attenuate Hyperglycemia through Endogenous Beta-Endorphin in Diabetic Rats
por: Cheng, Kai-Chun, et al.
Publicado: (2020)

High normotension is associated with future metabolic syndrome but not cardiovascular disease: A 10-year longitudinal study
por: Chen, Yen-Lin, et al.
Publicado: (2017)

Effect of body mass index on diabetogenesis factors at a fixed fasting plasma glucose level
por: Lin, Jiunn-Diann, et al.
Publicado: (2018)

Correction: Effect of body mass index on diabetogenesis factors at a fixed fasting plasma glucose level
por: Lin, Jiunn-Diann, et al.
Publicado: (2018)

Zafirlukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Reduces the Effect of Advanced Glycation End-Products in Rat Renal Mesangial Cells In Vitro
por: Yan, Liping, et al.
Publicado: (2019)

Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
por: Kang, Yu Mi, et al.
Publicado: (2016)

Hyperglycemia and advanced glycation end products (AGEs) suppress the differentiation of 3T3-L1 preadipocytes
por: Chang, Chia-Chu, et al.
Publicado: (2017)

Sitagliptin attenuates arterial calcification by downregulating oxidative stress-induced receptor for advanced glycation end products in LDLR knockout mice
por: Lin, Chih-Pei, et al.
Publicado: (2021)

An Emerging Role of Glucagon-Like Peptide-1 in Preventing Advanced-Glycation-End-Product-Mediated Damages in Diabetes
por: Puddu, Alessandra, et al.
Publicado: (2013)

The cardiovascular and renal effects of glucagon-like peptide 1 receptor agonists in patients with advanced diabetic kidney disease
por: Lin, Yuan, et al.
Publicado: (2023)

Cytoprotective Effect of Liposomal Puerarin on High Glucose-Induced Injury in Rat Mesangial Cells
por: Barro, Lassina, et al.
Publicado: (2021)

Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice
por: Pereira-Simon, Simone, et al.
Publicado: (2016)

Blockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats
por: Chen, Lei, et al.
Publicado: (2009)

Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists
por: Lin, Tzu-Yi, et al.
Publicado: (2023)

The roles of first phase, second phase insulin secretion, insulin resistance, and glucose effectiveness of having prediabetes in nonobese old Chinese women
por: Lu, Chieh-Hua, et al.
Publicado: (2020)

Impact of the Receptor for Advanced Glycation End Products Genetic Polymorphisms on the Progression in Uterine Cervical Cancer
por: Lee, Chung-Yuan, et al.
Publicado: (2018)

The glucagon‐like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents
por: Vallöf, Daniel, et al.
Publicado: (2015)

The Utilization of Glucagon-like Peptide 1 Agonists and Risk of Following External Eye Diseases in Type 2 Diabetes Mellitus Individuals: A Population-Based Study
por: Fan, Ying-Chi, et al.
Publicado: (2023)

Inhibitory Effects of Siegesbeckia orientalis Extracts on Advanced Glycation End Product Formation and Key Enzymes Related to Metabolic Syndrome
por: Hung, Wei-Chin, et al.
Publicado: (2017)

Soluble Form of Receptor for Advanced Glycation End Products Is Associated with Obesity and Metabolic Syndrome in Adolescents
por: He, Chih-Tsueng, et al.
Publicado: (2014)

The impact of receptor of advanced glycation end‐products polymorphisms on prostate cancer progression and clinicopathological characteristics
por: Chou, Ying‐Erh, et al.
Publicado: (2021)

The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still’s disease
por: Chen, Der-Yuan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9tcqpuftc6q93i6bbuk6hkec6v